1 |
Gongora, M.C., Qin, Z., Laude, K., Kim, H.W., McCann, L., Folz, J.R., Dikalov, S., Fukai, T. and Harrison, D.G. (2006) Role of extracellular superoxide dismutase in hypertension. Hypertension, 48, 473-481.
DOI
|
2 |
Zhan, C.D., Sindhu, R.K., Pang, J., Ehdaie, A. and Vaziri, N.D. (2004) Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet. J. Hypertens., 22, 2025-2033.
DOI
|
3 |
Welch, W.J., Chabrashvili, T., Solis, G., Chen, Y., Gill, P.S., Aslam, S., Wang, X., Ji, H., Sandberg, K., Jose, P. and Wilcox, C.S. (2006) Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension, 48, 934-941.
DOI
|
4 |
Carlsson, L.M., Marklund, S.L. and Edlund, T. (1996) The rat extracellular superoxide dismutase dimer is converted to a tetramer by the exchange of a single amino acid. Proc. Natl. Acad. Sci. U.S.A., 93, 5219-5222.
DOI
|
5 |
Landmesser, U., Dikalov, S., Price, S.R., McCann, L., Fukai, T., Holland, S.M., Mitch, W.E. and Harrison, D.G. (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest., 111, 1201-1209.
DOI
|
6 |
Pollock, D.M. and Rekito, A. (1998) Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers. Am. J. Physiol., 275, R1719-R1723.
|
7 |
Sullivan, J.C., Pollock, D.M. and Pollock, J.S. (2002) Altered nitric oxide synthase 3 distribution in mesenteric arteries of hypertensive rats. Hypertension, 39, 597-602.
DOI
|
8 |
Schneider, M.P., Wach, P.F., Durley, M.K., Pollock, J.S. and Pollock, D.M. (2010) Sex differences in acute ANG II-mediated hemodynamic responses in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol., 299, R899-R906.
DOI
|
9 |
Vera, T., Kelsen, S., Yanes, L.L., Reckelhoff, J.F. and Stec, D.E. (2007) HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. Am. J. Physiol. Regul. Integr. Comp. Physiol., 292, R1472-R1478.
DOI
|
10 |
Lewis, P., Stefanovic, N., Pete, J., Calkin, A.C., Giunti, S., Thallas-Bonke, V., Jandeleit-Dahm, K.A., Allen, T.J., Kola, I., Cooper, M.E. and de Haan, J.B. (2007) Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation, 115, 2178-2187.
DOI
|
11 |
Kang, K.T., Sullivan, J.C., Sasser, J.M., Imig, J.D. and Pollock, J.S. (2007) Novel nitric oxide synthase--dependent mechanism of vasorelaxation in small arteries from hypertensive rats. Hypertension, 49, 893-901.
DOI
|
12 |
Meng, S., Roberts, L.J., 2nd, Cason, G.W., Curry, T.S. and Manning, R.D., Jr. (2002) Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 283, R732- R738.
DOI
|
13 |
Sasser, J.M., Sullivan, J.C., Hobbs, J.L., Yamamoto, T., Pollock, D.M., Carmines, P.K. and Pollock, J.S. (2007) Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J. Am. Soc. Nephrol., 18, 143-154.
DOI
|
14 |
Westman, G. and Marklund, S.L. (1980) Diethyldithiocarbamate, a superoxide dismutase inhibitor, decreases the radioresistance of Chinese hamster cells. Radiat. Res., 83, 303-311.
DOI
|
15 |
Griendling, K.K., Sorescu, D. and Ushio-Fukai, M. (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res., 86, 494-501.
DOI
|
16 |
Kim, M., Han, C.H. and Lee, M.Y. (2014) NADPH oxidase and the cardiovascular toxicity associated with smoking. Toxicol. Res., 30, 149-157.
DOI
|
17 |
Kase, H., Hashikabe, Y., Uchida, K., Nakanishi, N. and Hattori, Y. (2005) Supplementation with tetrahydrobiopterin prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress. J. Hypertens., 23, 1375-1382.
DOI
|
18 |
Kang, K.T., Sullivan, J.C., Spradley, F.T., d'Uscio, L.V., Katusic, Z.S. and Pollock, J.S. Antihypertensive therapy increases tetrahydrobiopterin levels and NO/cGMP signaling in small arteries of angiotensin II-infused hypertensive rats. Am. J. Physiol. Heart. Circ. Physiol., 300, H718-H724.
|
19 |
Inscho, E.W., Cook, A.K., Murzynowski, J.B. and Imig, J.D. (2004) Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activation. J. Hypertens., 22, 811-818.
DOI
|
20 |
Vanourkova, Z., Kramer, H.J., Huskova, Z., Vaneckova, I., Opocensky, M., Chabova, V.C., Tesar, V., Skaroupkova, P., Thumova, M., Dohnalova, M., Mullins, J.J. and Cervenka, L. (2006) AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension. J. Hypertens., 24, 2465-2472.
DOI
|
21 |
Lip, G.Y., Edmunds, E., Nuttall, S.L., Landray, M.J., Blann, A.D. and Beevers, D.G. (2002) Oxidative stress in malignant and non-malignant phase hypertension. J. Hum. Hypertens., 16, 333-336.
DOI
|
22 |
Higashi, Y., Sasaki, S., Nakagawa, K., Matsuura, H., Oshima, T. and Chayama, K. (2002) Endothelial function and oxidative stress in renovascular hypertension. N. Engl. J. Med., 346, 1954-1962.
DOI
|
23 |
Wu, R., Millette, E., Wu, L. and de Champlain, J. (2001) Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J. Hypertens., 19, 741-748.
DOI
|
24 |
Ulker, S., McMaster, D., McKeown, P.P. and Bayraktutan, U. (2003) Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation. Cardiovasc. Res., 59, 488-500.
DOI
|
25 |
Uehara, Y., Numabe, A., Hirawa, N., Kawabata, Y., Iwai, J., Ono, H., Matsuoka, H., Takabatake, Y., Yagi, S. and Sugimoto, T. (1991) Antihypertensive effects of cicletanine and renal protection in Dahl salt-sensitive rats. J. Hypertens., 9, 719-728.
DOI
|
26 |
Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B.A., Griendling, K.K. and Harrison, D.G. (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest., 97, 1916-1923.
DOI
|
27 |
Russo, C., Olivieri, O., Girelli, D., Faccini, G., Zenari, M.L., Lombardi, S. and Corrocher, R. (1998) Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J. Hypertens., 16, 1267-1271.
DOI
|
28 |
Lee, M.Y. and Griendling, K.K. (2008) Redox signaling, vascular function, and hypertension. Antioxid. Redox. Signal., 10, 1045-1059.
DOI
|
29 |
Cai, H. and Harrison, D.G. (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res., 87, 840-844.
DOI
|
30 |
Karlsson, K. and Marklund, S.L. (1988) Extracellular superoxide dismutase in the vascular system of mammals. Biochem. J., 255, 223-228.
|
31 |
Beswick, R.A., Zhang, H., Marable, D., Catravas, J.D., Hill, W.D. and Webb, R.C. (2001) Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension, 37, 781-786.
DOI
|
32 |
Daiber, A., Mulsch, A., Hink, U., Mollnau, H., Warnholtz, A., Oelze, M. and Munzel, T. (2005) The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine. Am. J. Cardiol., 96, 25i-36i.
|
33 |
Marklund, S.L. (1984) Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem. J., 222, 649-655.
DOI
|
34 |
Jung, O., Marklund, S.L., Geiger, H., Pedrazzini, T., Busse, R. and Brandes, R.P. (2003) Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ. Res., 93, 622-629.
DOI
|
35 |
Fukai, T., Siegfried, M.R., Ushio-Fukai, M., Griendling, K.K. and Harrison, D.G. (1999) Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ. Res., 85, 23-28.
DOI
|
36 |
Griendling, K.K., Minieri, C.A., Ollerenshaw, J.D. and Alexander, R.W. (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res., 74, 1141-1148.
DOI
|
37 |
Didion, S.P., Kinzenbaw, D.A. and Faraci, F.M. (2005) Critical role for CuZn-superoxide dismutase in preventing angiotensin II-induced endothelial dysfunction. Hypertension, 46, 1147-1153.
DOI
|
38 |
Fukui, T., Ishizaka, N., Rajagopalan, S., Laursen, J.B., Capers, Q., Taylor, W.R., Harrison, D.G., de Leon, H., Wilcox, J.N. and Griendling, K.K. (1997) p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ. Res., 80, 45-51.
DOI
|
39 |
Kim, S.M. and Kang, J.H. (1997) Peroxidative activity of human Cu,Zn-superoxide dismutase. Mol. Cells, 7, 120-124.
|